Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
This is an INTENTION TO AWARD Notice following The Health Care Services (Provider Selection Regime) Regulations 2023 - Direct Award Process C (DAP C).
North of England Commissioning Support (NECS) is a commissioning support service working for and on behalf of NHS England North West (the Relevant Authority) who have undertaken a DAP C process to provide North West HPV Primary Cervical Screening Laboratory Service.
Contract Start Date: 01 July 2026
Contract End Date: 31 March 2029
The agreed contract term is an initial term of 21 months 01 July 2026 to 31 March 2028, with a further 1 year extension 01 April 2028 to March 2029.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Manchester University NHS Foundation Trust | Charity Commission: 1049274 | £29,975,000 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £29,975,000 initial term | 1 single bid — no competition | Manchester University NHS Foundation Trust | active |
Weightings from the notice.
Changes the buyer published to this notice after it first appeared.
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. This contract has now been formally awarded using Direct Award Process C.
For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using Direct Award Process C.
The contract was awarded on 30 June 2026, following the successful completion of the 8 day standstill period.
The agreed contract term is an initial term of 21 months 01 July 2026 to 31 March 2028, with a further 1 year extension 01 April 2028 to March 2029.
Contract Value: £29,975,000
The award decision was made by the NHS Greater Manchester Primary Care, Contract and Commissioning Group (PCCC), which included the following individuals; Director of Primary Care - NHS Greater Manchester, Assistant Director of Finance - Primary Care & Estates, Director of Transformation and Partnerships , Director of Finance , Chief Finance Officer - Health and Social Integration , Community Pharmacy Integration and Commissioning Portfolio Lead, Executive Director, Health and Adult Care and Deputy Place Lead - NHS GM (Bury).
No representations were brought to the Relevant Authority during the standstill period.
There were no conflicts of interests identified.